These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7474003)

  • 21. Unopposed interleukin-1 is necessary for increased plasma cytokine and eicosanoid levels to develop in severe sepsis.
    Slotman GJ; Quinn JV; Wry PC; Brathwaite CE; Friedman BM
    Ann Surg; 1997 Jul; 226(1):77-84. PubMed ID: 9242341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients.
    Pereira BJ; Shapiro L; King AJ; Falagas ME; Strom JA; Dinarello CA
    Kidney Int; 1994 Mar; 45(3):890-6. PubMed ID: 8196293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-1 beta induces interleukin-1 receptor antagonist and tumor necrosis factor binding protein in humans.
    Bargetzi MJ; Lantz M; Smith CG; Torti FM; Olsson I; Eisenberg SP; Starnes HF
    Cancer Res; 1993 Sep; 53(17):4010-3. PubMed ID: 8395334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is circulating endotoxin the trigger for the systemic inflammatory response syndrome seen after injury?
    Kelly JL; O'Sullivan C; O'Riordain M; O'Riordain D; Lyons A; Doherty J; Mannick JA; Rodrick ML
    Ann Surg; 1997 May; 225(5):530-41; discussion 541-3. PubMed ID: 9193181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.
    Drenth JP; van Deuren M; van der Ven-Jongekrijg J; Schalkwijk CG; van der Meer JW
    Blood; 1995 Jun; 85(12):3586-93. PubMed ID: 7780142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-1 contributes to increased concentrations of soluble tumor necrosis factor receptor type I in sepsis.
    van der Poll T; Fischer E; Coyle SM; Van Zee KJ; Pribble JP; Stiles DM; Barie PS; Buurman WA; Moldawer LL; Lowry SF
    J Infect Dis; 1995 Aug; 172(2):577-80. PubMed ID: 7622910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The IL-1 system in HIV infection: peripheral concentrations of IL-1beta, IL-1 receptor antagonist and soluble IL-1 receptor type II.
    Kreuzer KA; Dayer JM; Rockstroh JK; Sauerbruch T; Spengler U
    Clin Exp Immunol; 1997 Jul; 109(1):54-8. PubMed ID: 9218824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The dynamic responses of pro-inflammatory and anti-inflammatory cytokines of human mononuclear cells induced by uromodulin.
    Su SJ; Yeh TM
    Life Sci; 1999; 65(24):2581-90. PubMed ID: 10619366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-inflammatory properties of human serum IgA: induction of IL-1 receptor antagonist and Fc alpha R (CD89)-mediated down-regulation of tumour necrosis factor-alpha (TNF-alpha) and IL-6 in human monocytes.
    Wolf HM; Hauber I; Gulle H; Samstag A; Fischer MB; Ahmad RU; Eibl MM
    Clin Exp Immunol; 1996 Sep; 105(3):537-43. PubMed ID: 8809146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections.
    van Deuren M; van der Ven-Jongekrijg J; Demacker PN; Bartelink AK; van Dalen R; Sauerwein RW; Gallati H; Vannice JL; van der Meer JW
    J Infect Dis; 1994 Jan; 169(1):157-61. PubMed ID: 8277177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis.
    Sekiyama KD; Yoshiba M; Thomson AW
    Clin Exp Immunol; 1994 Oct; 98(1):71-7. PubMed ID: 7923888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human neutrophils produce high levels of the interleukin 1 receptor antagonist in response to granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha.
    McColl SR; Paquin R; Ménard C; Beaulieu AD
    J Exp Med; 1992 Aug; 176(2):593-8. PubMed ID: 1386877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strikingly higher interleukin (IL)-1alpha, IL-1beta and soluble interleukin-1 receptor antagonist (sIL-1RA) but similar IL-2, sIL-2R, IL-3, IL-4, IL-6, sIL-6R, IL-10, tumour necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta and interferon IFN-gamma urine levels in healthy females compared to healthy males: protection against urinary tract injury?
    Sadeghi M; Daniel V; Naujokat C; Weimer R; Opelz G
    Clin Exp Immunol; 2005 Nov; 142(2):312-7. PubMed ID: 16232218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of interleukin-1 receptor antagonist (IL-1RA) and tumor necrosis factor binding protein (TNF-BP) in a rodent abscess model of host resistance.
    Colagiovanni DB; Shopp GM
    Immunopharmacol Immunotoxicol; 1996 Aug; 18(3):397-419. PubMed ID: 8872492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55.
    Tilg H; Trehu E; Atkins MB; Dinarello CA; Mier JW
    Blood; 1994 Jan; 83(1):113-8. PubMed ID: 8274730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumour necrosis factor soluble receptors I and II and interleukin-1 receptor antagonist in acute pyelonephritis in relation to bacterial virulence-associated traits and renal function.
    Jacobson SH; Lu Y; Brauner A
    Nephrol Dial Transplant; 1996 Nov; 11(11):2209-14. PubMed ID: 8941580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Host-tumor interaction in ovarian cancer. Spontaneous release of tumor necrosis factor and interleukin-1 inhibitors by purified cell populations from human ovarian carcinoma in vitro.
    Burger RA; Grosen EA; Ioli GR; Van Eden ME; Brightbill HD; Gatanaga M; DiSaia PJ; Granger GA; Gatanaga T
    Gynecol Oncol; 1994 Nov; 55(2):294-303. PubMed ID: 7959299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin 1 beta, tumour necrosis factor-alpha and interleukin 1 receptor antagonist in newly diagnosed insulin-dependent diabetes mellitus: comparison to long-standing diabetes and healthy individuals.
    Netea MG; Hancu N; Blok WL; Grigorescu-Sido P; Popa L; Popa V; van der Meer JW
    Cytokine; 1997 Apr; 9(4):284-7. PubMed ID: 9112337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of circulating soluble tumour necrosis factor receptor and interleukin 1 receptor antagonist following interleukin 1 alpha infusion in humans.
    Tilg H; Trehu E; Shapiro L; Pape D; Atkins MB; Dinarello CA; Mier JW
    Cytokine; 1994 Mar; 6(2):215-9. PubMed ID: 8032003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass.
    Gormley SM; McBride WT; Armstrong MA; McClean E; MacGowan SW; Campalani G; McMurray TJ
    Cytokine; 2002 Jan; 17(2):61-5. PubMed ID: 11886172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.